Clinical Trial Update: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BCD-100 (anti-PD-1) with platinum-based chemotherapy and bevacizumab for recurrent, persistent, or metastatic cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• BCD-100 (unclear)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Biocad | Conditions: Cervical Cancer, Cervical Cancer Metastatic | Phase 2 | Status: UNKNOWN